Founder relief

US-Dutch medical device company EndoStim, developer of neurostimulation therapy for gastroesophageal reflux disease, has named ­Rohan Hoare as president and CEO. He succeeds founder Bevil Hogg, who will continue to serve the company as a consultant.

ADVERTISEMENT

Hoare, who holds a Master of Arts and a PhD in physics from Harvard University, was previously president of the Neuromodulation business unit of Livanova, the London-based company formed by the merger of Cyberonics and Sorin Group.

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!